Summary by Futu AI
SeaStar Medical Holding Corporation, a medical device company, has announced the completion of a 25-for-1 reverse stock split, effective as of 5:00 p.m. EDT on June 7, 2024. The reverse stock split was previously approved by the company's stockholders during a Special Meeting on September 6, 2023. Trading on a split-adjusted basis will commence on the Nasdaq Capital Market under the existing ticker symbol 'ICU' starting June 10, 2024. The reverse split aims to increase the market price of SeaStar Medical's common stock to meet Nasdaq's minimum bid price requirement. Post-split, the company will have approximately 3.1 million shares of common stock issued and outstanding. The company's transfer agent, Colonial Stock Transfer Company, Inc., will act as the exchange agent for...Show More